Instituto de Investigaciones Clínicas Mar del Plata
Somos una organización que trabaja en la generación de conocimiento para mejorar la calidad de vida de las personas a través de la investigación clínica. Trabajamos con un fuerte interés en concientizar y educar a la sociedad sobre la prevención y tratamiento de enfermedades y sobre la importancia de los ensayos clínicos para lograrlo.Av. Colón 3456, Mar del Plata, Buenos Aires
Select an option
I am a doctor
I am a sponsor
Specializations
Cáncer de pulmón
Diabetes
Obesidad
Taquicardia supraventricular paroxística
Hipertensión arterial pulmonar
Cáncer de próstata
Fibrosis pulmonar
Cáncer de útero
Cardiovascular
Cáncer de mama
Insuficiencia cardíaca
Cáncer de riñón
Enfermedad renal crónica
Patients Benefits
Refrigerio
Viáticos
Our team
Authorities
Médico clínico e investigador
Cardiovascular Research Department, Head & Co-FounderIgnacio Jorge MacKinnon
Medical staff
Médico especialista en oncología 
Médico clínico investigador
Médica investigadora 
Médico Especialista en Infectología
Médico clínico e investigador
Investigador PrincipalIgnacio Alfredo Casarini
Investigador PrincipalSergio Andrés Nemi
Investigadora PrincipalNatalia Cluigt
Investigador PrincipalGonzalo Corral
Investigador PrincipalPablo Martinez Monferrán
Investigador PrincipalPablo Corral
Maria Treutel
Investigador PrincipalJavier Daverio
Sub-investigadora Micaela Leis
Investigadora PrincipalVirginia Laura Sernia
Legal and Administrative staff
Chief Operating OfficerClarisa De Luca
Clinical Research AssistantAgostina Villalba
Junior Clinical Research CoordinatorCamila Onorio
Senior Clinical Research CoordinatorMaría Luján Álvarez
Pharmacy StaffCarmela Coppa
Regulatory Clinical Research CoordinatorCecilia Lambrecht
Administration ManagerJorge Eramuspe
Management Control ManagerFlorencia Lozano
ReceptionistLorena Dilesi
Clinical Research AssistantFlorencia Stabile Moritan
Chief Financial OfficerMaría Inés Bello
HRPaola Prestes
ReceptionistVanessa De Lisi
Recruitment CoordinatorPia Leone
Laboratory StaffPamela Delmonte
Clinical Research AssistantSelene Juarez
Clinical Research AssistantPaola Gambini
ReceptionistRomina Moggia
Laboratory StaffTamara Llopiz
Administration AssistantValentina Carrin
Clinical Research AssistantVeronica Portela
Laboratory StaffLidia Bustamante
Clinical Research AssistantVictoria Vetruel
Clinical Research CoordinatorAriana Balcarce
Open studies
Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer - OPERA-01 - Olema Pharmaceuticals, Inc.See more
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) - MK-6482-029 LITESPARK-029 - Merck Sharp & Dohme LLCSee more
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) - TroFuse-011 - Merck Sharp & Dohme LLCSee more
Prostate cancer
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) - MK-5684-003 - Merck Sharp & Dohme LLCSee more
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). - MEVPRO-1 - PfizerSee more
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. - MEVPRO-2 - PfizerSee more
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) - IDeate-Prostate01 - Merck Sharp & Dohme LLCSee more
Lung cancer
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - INTerpath-002 - Merck Sharp & Dohme LLCSee more
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) - MK-1084-004 - Merck Sharp & Dohme LLCSee more
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] - MK-2870-023 - Merck Sharp & Dohme LLCSee more
Arterial hypertension
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. - BaxDuo-Arctic - AstraZenecaSee more
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure - BaxDuo-Pacific - AstraZenecaSee more
Renal disease
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. - BaxDuo-Arctic - AstraZenecaSee more
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure - BaxDuo-Pacific - AstraZenecaSee more
Alzheimer disease
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) - Merck Sharp & Dohme LLCSee more
Bladder Cancer
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) - Merck Sharp & Dohme LLCSee more
Colorectal cancer
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more
Covid-19
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) - MOVe-NOW - Merck Sharp & Dohme LLCSee more
Dementia
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) - Merck Sharp & Dohme LLCSee more
Endometrial Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) - TroFuse-033 - Merck Sharp & Dohme LLCSee more
Non-Hodgkin Lymphoma
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) - waveLINE-010 - Merck Sharp & Dohme LLCSee more
